Percutaneous and surgical left atrial appendage occlusion in non-valvular atrial fibrillation: Contemporary narrative

Julian A Chestaro1, Hannah Price1, Joel Matthews2

  • 1Grand Strand Medical Center, Myrtle Beach, South Carolina, USA.

Insights

Left atrial appendage occlusion (LAAO) via surgical or percutaneous methods effectively reduces stroke risk in atrial fibrillation patients. Current evidence does not show one method is superior, with more data supporting percutaneous LAAO.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Atrial fibrillation (AF) patients contraindicated for oral anticoagulation (OAC) face high thromboembolic risk.
  • Left atrial appendage occlusion (LAAO) offers an alternative to reduce this risk.
  • Both surgical (S-LAAO) and percutaneous (pLAAO) approaches exist, but direct comparative data is limited.

Purpose of the Study:

  • To review and compare the evidence for S-LAAO and pLAAO.
  • To assess procedural safety, thromboembolic outcomes, and LAA exclusion completeness.
  • To evaluate the role of various imaging modalities in LAAO.

Main Methods:

  • Contemporary narrative review of randomized controlled trials (RCTs) and systematic reviews (SRs).
  • Focused literature search on safety, efficacy, and imaging.
  • Assessment of pre-, intra-, and post-procedural imaging evidence.

Main Results:

  • Both S-LAAO and pLAAO reduce thromboembolic events.
  • S-LAAO shows strong evidence when performed during cardiac surgery; isolated S-LAAO evidence is limited.
  • pLAAO demonstrates noninferiority to OAC in select populations; incomplete occlusion is a concern for both methods.

Conclusions:

  • S-LAAO and pLAAO are effective in reducing thromboembolic risk, with no established superiority.
  • Evidence is more robust for pLAAO, while S-LAAO is mainly studied in conjunction with cardiac surgery.
  • Further comparative studies are needed, focusing on residual patency, antithrombotic therapy, and advanced imaging.
Abstract